BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31534497)

  • 1. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.
    Jia J; Zhang HB; Shi Q; Yang C; Ma JB; Jin B; Wang X; He D; Guo P
    Theranostics; 2019; 9(19):5464-5477. PubMed ID: 31534497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
    Lin JZ; Wang WW; Hu TT; Zhu GY; Li LN; Zhang CY; Xu Z; Yu HB; Wu HF; Zhu JG
    Cancer Lett; 2020 Jan; 469():481-489. PubMed ID: 31738958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
    Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
    Laha D; Deb M; Das H
    Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
    Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
    Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
    Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
    Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells.
    Wang Q; He WY; Zeng YZ; Hossain A; Gou X
    Int Urol Nephrol; 2018 Apr; 50(4):675-686. PubMed ID: 29460131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1.
    Ma JB; Bai JY; Zhang HB; Jia J; Shi Q; Yang C; Wang X; He D; Guo P
    Cell Death Dis; 2020 Jun; 11(6):466. PubMed ID: 32546700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3.
    Hu F; Zhao Y; Yu Y; Fang JM; Cui R; Liu ZQ; Guo XL; Xu Q
    Cancer Lett; 2018 Mar; 416():24-30. PubMed ID: 29246644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth.
    Zhang M; Sun Y; Meng J; Zhang L; Liang C; Chang C
    Cancer Lett; 2019 Feb; 442():483-490. PubMed ID: 30423407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy: Erratum.
    Jia J; Zhang HB; Shi Q; Yang C; Ma JB; Jin B; Wang X; He D; Guo P
    Theranostics; 2023; 13(9):2962-2963. PubMed ID: 37284453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
    Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation.
    Chen R; Wang H; Liang B; Liu G; Tang M; Jia R; Fan X; Jing W; Zhou X; Wang H; Yang Y; Wei H; Li B; Zhao J
    Cell Death Dis; 2016 Dec; 7(12):e2512. PubMed ID: 27929538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.
    Shi Q; Gao Y; Xu S; Du C; Li F; Tang XS; Jia J; Wang X; Chang L; He D; Guo P
    Urol Oncol; 2016 Feb; 34(2):58.e11-8. PubMed ID: 26480897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.
    Hu R; Li T; Hui K; Chen Z; Wang N; Wu X; Ge L; Zhou L
    Mol Med Rep; 2020 Nov; 22(5):3935-3943. PubMed ID: 32901884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.
    Muniyan S; Rachagani S; Parte S; Halder S; Seshacharyulu P; Kshirsagar P; Siddiqui JA; Vengoji R; Rauth S; Islam R; Mallya K; Datta K; Xi L; Das A; Teply BA; Kukreja RC; Batra SK
    Clin Cancer Res; 2020 Nov; 26(21):5720-5734. PubMed ID: 32847934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 18. Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
    Hansen AR; Tannock IF; Templeton A; Chen E; Evans A; Knox J; Prawira A; Sridhar SS; Tan S; Vera-Badillo F; Wang L; Wouters BG; Joshua AM
    Oncologist; 2019 Sep; 24(9):1188-1194. PubMed ID: 30952818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.
    Pan B; Chen D; Huang J; Wang R; Feng B; Song H; Chen L
    Mol Cancer; 2014 Jul; 13():165. PubMed ID: 24996221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.
    Yasumizu Y; Miyajima A; Kosaka T; Miyazaki Y; Kikuchi E; Oya M
    J Urol; 2014 Jan; 191(1):227-34. PubMed ID: 23954373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.